Candesartan Reduces the Innate Immune Response to Lipopolysaccharide in Human Monocytes
Journal of Hypertension - United States
doi 10.1097/hjh.0b013e3283314bc7
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2009
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)